Consistently with these reports, in the novel ApoE−/− rat model used herein, RDN reduced plasma aldosterone levels and attenuated aortic medial fibrosis formation, while hyperlipidemia and cardiac parameters were not affected. Here, APOE is linked to hyperlipidemia.